Kazakhstan’s AIFC discussing stock-trading links with Shanghai, Hong Kong



The Astana International Financial Centre (AIFC), a special economic zone in the Kazakhstan capital, is in discussions with Hong Kong and Shanghai’s equity exchanges about the creation of stock connection schemes, most likely starting with exchange-traded funds (ETFs), to widen investors’ access to each other’s markets.

According to AIFC’s governor Renat Bekturov, Kazakh investors’ interest in Chinese companies, from hi-tech behemoths to carmakers, was growing, inspiring organisations in both China and Kazakhstan to copy the success of existing cross-border trading schemes.

“We have to think about it because a lot of the Chinese brands are quite well known in Kazakhstan, like Tencent [Holdings] which owns WeChat and carmaker BYD,” he said in an interview last week. “Investors in Kazakhstan would be very interested to become part of those growth stories.”

At the same time, mainland Chinese and Hong Kong investors would also be keen to own shares of mining companies in his country, the governor added.

An ETF exchange between Kazakhstan and China would be likely to be denominated in the Kazakh tenge and the Chinese yuan, extending a 7 billion yuan (US$982 million) and 200 billion tenge (US$371 million) currency swap agreed in 2014 by the two countries.

Bekturov was in Shanghai to attend a conference focused on capital connection with the mainland’s financial hub, where he met senior government officials, representatives from China’s leading financial institutions and business leaders.

  • Related Posts

    Japan’s exports jump 19.3% in June, extend growth streak to 10 months despite Iran war disruptions – Firstpost

    Japan’s exports rose for a 10th consecutive month in June, beating market expectations as a weak yen and robust demand linked to artificial intelligence-related data centres helped offset disruptions to…

    Continue reading
    0% for two years, 100% from 2028 and 200% thereafter – Firstpost

    US President Donald Trump has announced a phased tariff plan for imported generic medicines, giving drugmakers two years to shift production to the United States before facing steep import duties.…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *